Pharma Capital

Featured articles

VIEW ALL ARTICLES

Featured companies

We are a drug development company with a proprietary genetic medicine platform Our technol...
VentriPoint is a public company (TSXV: VPT) dedicated to making heart analysis convenient and ...
Novogen (ASX:NRT, NASDAQ:NVGN) is listed on the Australian Securities Exchange.
We provide information to healthcare professionals about the prevention, diagnosis and treatme...
OUR VISION Unibio’s vision is to be the leading producer of methane based products, such a...
ValiRx Plc is a life science company, which focuses on clinical stage cancer therapeutic devel...

Executive video interviews

VIEW ALL VIDEOS

Big picture investment ideas in Biotech Capital

VIEW ALL

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.